BCM
INSM icon

Bridgeway Capital Management’s Insmed INSM Stock Holding History

Bridgeway Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-12,200
Closed -$221K – 1459
2015
Q4 		$221K Buy
+12,200
New +$215K ﹤0.01% 1277

Other funds holding INSM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bridgeway Capital Management's INSM Position: Q1 2016 in Review

Bridgeway Capital Management sold out of Insmed (INSM) in Q1 2016, closing a stake of 12,200 shares — an estimated $221K sold.

Bridgeway Capital Management first reported a position in INSM in Q4 2015 and held it in 1 quarter. The position peaked at $221K in Q4 2015. 101 funds tracked by Wall St. Rank hold INSM as of Q1 2016.

  • Bridgeway Capital Management reported no remaining Insmed position as of Q1 2016 after selling out during the quarter.
  • Bridgeway Capital Management sold 12,200 Insmed shares in Q1 2016, an estimated $221K.
  • Bridgeway Capital Management first reported a position in Insmed in Q4 2015 and held it in 1 quarter.
  • Bridgeway Capital Management's Insmed position peaked at $221K in Q4 2015.
  • 101 funds tracked by Wall St. Rank held Insmed as of Q1 2016.

Based on Bridgeway Capital Management's 13F filing for Q1 2016, filed 16 May 2016.